Insmed Inc’s recent filing unveils that its Chair and CEO Lewis William unloaded Company’s shares for reported $1.31 million on Dec 19 ’24. In the deal valued at $69.91 per share,18,750 shares were sold. As a result of this transaction, Lewis William now holds 384,960 shares worth roughly $26.51 million.
Then, Lewis William sold 6,830 shares, generating $477,550 in total proceeds. Upon selling the shares at $69.92, the Chair and CEO now owns 233,924 shares.
Before that, Lewis William bought 25,580 shares. Insmed Inc shares valued at $1,787,524 were divested by the Officer at a price of $69.88 per share.
Truist initiated its Insmed Inc [INSM] rating to a Buy in a research note published on April 23, 2024; the price target was $48. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid February with a ‘”an Outperform”‘ rating. Wells Fargo began covering INSM with “an Overweight” recommendation on December 08, 2023.
Price Performance Review of INSM
On Monday, Insmed Inc [NASDAQ:INSM] saw its stock fall -1.06% to $68.87. Over the last five days, the stock has lost -2.23%. Insmed Inc shares have risen nearly 122.23% since the year began. Nevertheless, the stocks have risen 116.98% over the past one year. While a 52-week high of $80.53 was reached on 08/22/24, a 52-week low of $21.92 was recorded on 05/24/24. SMA at 50 days reached $71.84, while 200 days put it at $59.86.
Levels Of Support And Resistance For INSM Stock
The 24-hour chart illustrates a support level at 67.75, which if violated will result in even more drops to 66.62. On the upside, there is a resistance level at 69.80. A further resistance level may holdings at 70.72. The Relative Strength Index (RSI) on the 14-day chart is 40.38, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.56, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 82.65%. Stochastics %K at 17.82% indicates the stock is a buying.
How much short interest is there in Insmed Inc?
A steep rise in short interest was recorded in Insmed Inc stocks on 2024-12-13, growing by 0.91 million shares to a total of 13.01 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 12.1 million shares. There was a rise of 6.99%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on July 26, 2023 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $50 price target.
